# The Use of ACE Inhibitors in the Early Renal Post-transplant Period

> **NCT00270153** · PHASE1 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 110 (actual)

## Conditions studied

- Renal Transplant

## Interventions

- **DRUG:** enalapril
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00270153
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2019-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00270153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00270153, "The Use of ACE Inhibitors in the Early Renal Post-transplant Period". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00270153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*